IBA, based in Belgium, is a global leader in particle accelerator technology, focusing on innovative solutions for cancer diagnosis and treatment among other serious illnesses.
Company Overview
IBA, based in Belgium, is a global leader in particle accelerator technology. With over 2000 employees worldwide, the company is committed to developing, installing, and maintaining safe, robust, and compliant products for customers globally. IBA is a certified B Corp, and its mission is to protect, enhance, and save lives through its innovative solutions.
Services
IBA offers a comprehensive range of services, including Proton Therapy, Dosimetry, RadioPharma Solutions, and Industrial Solutions. These services are designed to provide innovative solutions for the diagnosis and treatment of cancer and other serious illnesses. The company's offerings aim to meet the diverse needs of healthcare providers and patients around the world.
Global Presence
IBA has a significant global presence, with offices in Canada, China, Germany, Russia, and the USA. This extensive network allows the company to support its international customer base effectively. By maintaining a strong presence in key markets, IBA can provide localized service and support to its clients.
Innovation in Particle Accelerator Technology
IBA continues to innovate in the field of particle accelerator technology, spearheading advancements that enhance the diagnosis and treatment of serious diseases. As a world leader in this domain, the company's ongoing research and development efforts focus on creating cutting-edge, reliable, and efficient technologies.